Literature DB >> 18191274

Necrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type Ia.

So Youn Kim1, David A Weinstein, Matthew F Starost, Brian C Mansfield, Janice Y Chou.   

Abstract

BACKGROUND/AIMS: Glycogen storage disease type Ia (GSD-Ia) patients manifest the long-term complication of hepatocellular adenoma (HCA) of unknown etiology. We showed previously that GSD-Ia mice exhibit neutrophilia and elevated serum cytokine levels. This study was conducted to evaluate whether human GSD-Ia patients exhibit analogous increases and whether in GSD-Ia mice a correlation exists between immune abnormalities and, biochemical and histological alterations in the liver.
METHODS: Differential leukocyte counts and cytokine levels were investigated in GSD-Ia patients. Hepatic chemokine production, neutrophil infiltration, and histological abnormalities were investigated in GSD-Ia mice.
RESULTS: We show that GSD-Ia patients exhibit increased peripheral neutrophil counts and serum interleukin-8 (IL-8). Compared to normal subjects, HCA-bearing GSD-Ia patients have a 2.8-fold higher serum IL-8 concentration, while GSD-Ia patients without HCA have a 1.4-fold higher concentration. Hepatic injury in GSD-Ia mice is evidenced by necrotic foci, markedly elevated infiltrating neutrophils, and increased hepatic production of chemokines.
CONCLUSIONS: Peripheral neutrophilia and elevated serum chemokines are characteristic of GSD-Ia with HCA-bearing GSD-Ia patients having the highest serum IL-8. In GSD-Ia mice these elevations correlate with elevated hepatic chemokine levels, neutrophil infiltration, and necrosis. Taken together, peripheral neutrophilia and increased serum chemokines may indicate hepatic injuries in GSD-Ia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18191274      PMCID: PMC2744599          DOI: 10.1016/j.jhep.2007.11.014

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  40 in total

Review 1.  Structure, function, and inhibition of chemokines.

Authors:  Elias J Fernandez; Elias Lolis
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

Review 2.  Chemokine receptors and their role in inflammation and infectious diseases.

Authors:  C Murdoch; A Finn
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

Review 3.  Glycogen storage disease type I: pathophysiology of liver adenomas.

Authors:  Philip J Lee
Journal:  Eur J Pediatr       Date:  2002-07-12       Impact factor: 3.183

4.  Glucose-6-phosphatase gene mutations in 20 adult Japanese patients with glycogen storage disease type 1a with reference to hepatic tumors.

Authors:  T Nakamura; T Ozawa; T Kawasaki; H Nakamura; H Sugimura
Journal:  J Gastroenterol Hepatol       Date:  2001-12       Impact factor: 4.029

Review 5.  Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.

Authors:  Janice Yang Chou; Dietrich Matern; Brian C Mansfield; Yuan-Tsong Chen
Journal:  Curr Mol Med       Date:  2002-03       Impact factor: 2.222

6.  Expression and function of interleukin-8 in human hepatocellular carcinoma.

Authors:  J Akiba; H Yano; S Ogasawara; K Higaki; M Kojiro
Journal:  Int J Oncol       Date:  2001-02       Impact factor: 5.650

Review 7.  Cytokine cascades and the hepatic inflammatory response to ischemia and reperfusion.

Authors:  Tomohisa Okaya; Alex B Lentsch
Journal:  J Invest Surg       Date:  2003 May-Jun       Impact factor: 2.533

8.  Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter.

Authors:  Li-Yuan Chen; Jeng-Jer Shieh; Baochuan Lin; Chi-Jiunn Pan; Ji-Liang Gao; Philip M Murphy; Thomas F Roe; Shimon Moses; Jerrold M Ward; Eric J Lee; Heiner Westphal; Brian C Mansfield; Janice Yang Chou
Journal:  Hum Mol Genet       Date:  2003-08-12       Impact factor: 6.150

9.  Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes.

Authors:  Swati Joshi-Barve; Shirish S Barve; Kiranmayi Amancherla; Leila Gobejishvili; Daniell Hill; Matthew Cave; Prachi Hote; Craig J McClain
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

10.  Hepatic adenomatosis in glycogen storage disease type Ia: report of a case with unusual histology.

Authors:  Keith E Volmar; James L Burchette; Andrew J Creager
Journal:  Arch Pathol Lab Med       Date:  2003-10       Impact factor: 5.534

View more
  11 in total

Review 1.  Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy.

Authors:  Janice Y Chou; Hyun Sik Jun; Brian C Mansfield
Journal:  Nat Rev Endocrinol       Date:  2010-10-26       Impact factor: 43.330

2.  Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.

Authors:  Young Mok Lee; Hyun Sik Jun; Chi-Jiunn Pan; Su Ru Lin; Lane H Wilson; Brian C Mansfield; Janice Y Chou
Journal:  Hepatology       Date:  2012-08-27       Impact factor: 17.425

3.  Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy.

Authors:  Wai Han Yiu; Young Mok Lee; Wen-Tao Peng; Chi-Jiunn Pan; Paul A Mead; Brian C Mansfield; Janice Y Chou
Journal:  Mol Ther       Date:  2010-04-13       Impact factor: 11.454

4.  Neonatal gene therapy of glycogen storage disease type Ia using a feline immunodeficiency virus-based vector.

Authors:  Albert Grinshpun; Reba Condiotti; Simon N Waddington; Michael Peer; Eli Zeig; Sima Peretz; Alina Simerzin; Janice Chou; Chi-Jiunn Pann; Hilla Giladi; Eithan Galun
Journal:  Mol Ther       Date:  2010-06-22       Impact factor: 11.454

Review 5.  Recombinant AAV-directed gene therapy for type I glycogen storage diseases.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Expert Opin Biol Ther       Date:  2011-04-20       Impact factor: 4.388

Review 6.  Studies on glycogen storage disease type 1a animal models: a brief perspective.

Authors:  Irina O Petrova; Svetlana A Smirnikhina
Journal:  Transgenic Res       Date:  2022-08-25       Impact factor: 3.145

Review 7.  Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease.

Authors:  Fabienne Rajas; Julie Clar; Amandine Gautier-Stein; Gilles Mithieux
Journal:  J Inherit Metab Dis       Date:  2014-08-28       Impact factor: 4.982

Review 8.  Glycogen storage disease type Ia in canines: a model for human metabolic and genetic liver disease.

Authors:  Andrew Specht; Laurie Fiske; Kirsten Erger; Travis Cossette; John Verstegen; Martha Campbell-Thompson; Maggie B Struck; Young Mok Lee; Janice Y Chou; Barry J Byrne; Catherine E Correia; Cathryn S Mah; David A Weinstein; Thomas J Conlon
Journal:  J Biomed Biotechnol       Date:  2011-01-03

9.  Development of hepatocellular adenomas and carcinomas in mice with liver-specific G6Pase-α deficiency.

Authors:  Roberta Resaz; Cristina Vanni; Daniela Segalerba; Angela R Sementa; Luca Mastracci; Federica Grillo; Daniele Murgia; Maria Carla Bosco; Janice Y Chou; Ottavia Barbieri; Luigi Varesio; Alessandra Eva
Journal:  Dis Model Mech       Date:  2014-09       Impact factor: 5.758

10.  "Bull's eye" appearance of hepatocellular adenomas in patients with glycogen storage disease type I - atypical magnetic resonance imaging findings: Two case reports.

Authors:  Federica Vernuccio; Stephanie Austin; Mathias Meyer; Cynthia D Guy; Priya S Kishnani; Daniele Marin
Journal:  World J Clin Cases       Date:  2021-02-06       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.